Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion type Assertion NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_head.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion description "[AML1 point mutation is one of the major driving forces of myelodysplastic syndrome and acute myeloid leukemia, and these mutations may represent a distinct clinicopathologic-genetic entity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_provenance.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion evidence source_evidence_literature NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_provenance.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion SIO_000772 14615365 NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_provenance.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion wasDerivedFrom lhgdn-20090331 NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_provenance.
- NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_assertion wasGeneratedBy ECO_0000203 NP202199.RAMnOVMBKcZnChvmFlIRDWS17rj06MzFZg_iQ5o_rN61I130_provenance.